Electrotransfer of plasmid DNA in skeletal muscle is a common non-viral delivery method for both therapeutic genes and DNA vaccines. Yet, despite the similar approaches, an immune response is detrimental in gene therapy, but desirable for vaccines. However, the full nature of the immune and tissue responses to nucleic acids and electrotransfer in skeletal muscle has not been addressed. Here we used microarray analysis, fluorescence-activated cell sorting and quantitative polymerase chain reaction to obtain the molecular and cellular signature of the tissue and immune response to electrotransfer of saline and non-coding plasmid DNA. Saline electrotransfer resulted in limited infiltration and induction of a moderate damage --repair gene expression pattern not involving innate immune activation. However, plasmid electrotransfer augmented expression of the same genes in addition to inducing a strong innate immune response associated with pro-inflammatory infiltration. In particular, the inflammasome, Toll-like receptor 9 and other pattern recognition receptors able to respond to cytoplasmic DNA were upregulated. Several key differences in the nature of the inflammatory infiltrate and the kinetics of gene expression were also identified when comparing electrotransfer of conventional and CpG-free plasmids. Our data provide insights into the mechanisms of DNA detection and response in muscle that has relevance for non-viral gene therapy and DNA vaccination.
INTRODUCTION
Successful gene delivery to skeletal muscle is a desirable goal not only for the treatment of muscle diseases, but also for immunisation and treatment of systemic and metabolic disorders. Although naked DNA uptake into skeletal muscle is possible, 1 it is largely inefficient without additional chemical or physical delivery systems. Among non-viral strategies, electrotransfer (ET) has emerged as one of the most efficient methods for gene delivery both in vitro and in vivo. 2 The technique is based on the introduction of a nucleic acid solution, followed by immediate application of an electric field that enhances cell permeability and provides an electrophoretic force to the nucleic acid. 2 Skeletal muscle has several features that make it more readily amenable to this technique, including accessibility, the ability to stably retain episomal gene cassettes due to its non-dividing nature and its potential to secrete molecules into the circulation. 3 Extensive investigation by many groups over the past decade has enabled vast improvements in the technology and transduction efficiency, 2 such that it has now been successfully used in pre-clinical and clinical trials for the delivery of therapeutic plasmids 4 and DNA vaccines. 5, 6 However, two unresolved aspects of ET are the underlying nature of any tissue response to the ET process as a measure of safety and/or any immunological response induced by the procedure and/or nucleic acid itself. With regard to safety, the continued evolution of new ET conditions and non-viral delivery agents towards the clinic necessitates a firm understanding of tissue responses and the development of appropriate tools for assessing and minimising potential adverse events. Similarly, immune responses to gene therapy vectors are also of growing clinical relevance. 7 Importantly for skeletal muscle, ET is the growing awareness of the paradox between therapeutic and DNA vaccine-based approaches. 8 In this instance, an immune response to therapeutic plasmids and/or proteins is clearly deleterious, whereas it is a desired outcome for vaccine action, despite the fact that both approaches are performed almost identically. The immune response itself is a highly complex process dependent on the disease state, target tissue, vector dose, toxicity of transgene expression and its potency as an antigen, particularly if it is recognised as a neo-antigen. 7 In addition to anti-vector and antitransgene responses, DNA alone may also activate an immune response as it can act as a pathogen-associated molecular pattern detected by a rapidly expanding range of pathogen recognition receptors (PRRs) of the innate immune system. For example, it is widely reported that DNA, in particular non-methylated CpG motifs, are recognised by Toll-like receptor 9 (TLR9). 9, 10 However, a wealth of recent studies also point to the emergence of several alternative PRR pathways, including the inflammasome, in the direct and indirect recognition of single-strand and double-strand DNA and RNA directly in the cytoplasm. 11 --14 The role of these pathways in non-viral gene delivery to skeletal muscle has not been explored.
Therefore, we performed gene expression and cell profiling of skeletal muscle after ET with non-coding plasmid DNA or saline to identify a pattern of genes (the molecular signature) that serves as a biomarker of clinically relevant parameters (safety) and for identifying novel genetic pathways and potential therapeutic targets for improving vaccines or gene therapy. Our results confirm that ET in the absence of DNA is a mild process despite some tissue damage. In contrast, after DNA ET, we identified a strong and specific innate immune response involving upregulation of genes associated with both TLR9-dependent and alternative or TLR9-independent pathways of DNA recognition. We also assessed the outcome of diminishing the role of TLR9 in inducing the immune response by employing CpG-free plasmids. CpG-free plasmids induced a similar gene profile to conventional plasmids, but with a diminished intensity of expression and with significantly different kinetics of cellular infiltration, resolving more rapidly to an anti-inflammatory state. Our data provide insights into the potential pathways associated with DNA detection in skeletal muscle that will have relevance not only for ET, but also for other non-viral applications, as well as providing a platform for understanding the fundamental response to DNA vaccines.
RESULTS

Global analysis of gene expression profiles
To assess the immunological and tissue response of plasmid DNA in skeletal muscle to ET, we performed microarray analysis on total RNA taken from whole tibialis anterior muscles of untreated control (CN) mice, or from mice 7 days after ET with either salineonly (ET), or after injection of a single high dose of 75 mg of the non-coding plasmid pCMV (pET). We used a non-coding plasmid to avoid effects of protein synthesis and/or foreign antigen production.
After normalisation and statistical filtering, we identified a total of 571 probe-sets twofold up-or downregulated relative to CN (Figure 1a and Supplementary Tables 1 --7 for a comprehensive list  of genes) . Only 70 up-and 27 downregulated probe-sets were identified in ET muscles. In contrast, a more dramatic induction of gene expression changes was seen in pET muscles involving 467 upregulated and 40 downregulated probe-sets. Of the 467 upregulated probe-sets, 46 were upregulated in both ET and pET samples, suggesting that they form the foundation of a common tissue response/repair mechanism, whereas 421 probe-sets were unique to pET and form the basis of the specific tissue response to plasmid (Figures 1a and b) . Although the 24 probe-sets uniquely upregulated in ET muscle comprised several transcription factors (Supplementary Table 1 ), no further analysis was performed owing to the low number of genes in this group. Similarly, as we detected only five probe-sets commonly downregulated between ET and pET (Figure 1a ), and as all downregulated genes represented diverse gene ontology (GO) Biological Process terms (Supplementary Tables 2, 4 and 6 ; data not shown), we also discontinued analysis of this group. Finally, we also detected an outlying cluster of 18 protease genes, which showed exaggerated upregulation in ET, but not pET samples (Figure 1c ). We could not confirm this upregulation by quantitative real-time reverse transcription-polymerase chain reaction (qPCR) (data not shown), and as all 18 probe-sets correspond to genes with pancreatic protease function (for example, pancreatic elastase, trypsin, and so on) (data not shown), they were not taken into further consideration.
We next analysed the quantitative relationship in gene expression between the two conditions by plotting the log 2 fold-change values for each gene twofold or more up-or downregulated with ET and pET values on a different axis (Figure 1c) . If the tissue response was quantitatively equal, a linear Figure 1 . Global analysis of gene expression changes induced by electrotransfer of saline and non-coding plasmid in skeletal muscle. (a) The number of genes up-and downregulated in mouse skeletal muscle 7 days after electrotransfer with saline-only (ET; green), non-coding pCMV (pET; orange) or commonly upregulated in both conditions (blue), relative to untreated CN (Benjamini and Hochberg; Po0.05). (b) GO Term Enrichment analysis 15 was used to create a biological description of the two major sets of genes (see text for details). The number of probesets per GO term is shown below each title and some GO terms were merged for graphical simplicity: muscle refers to muscle structural genes and/or muscle-specific transcription factors; immune and defence response includes these two terms as well as inflammatory response and response to wounding. The 'miscellaneous' category includes 14 terms with p4 probe-sets term. (c) Quantitative analysis of probe-sets twofold up-or downregulated in ET (x axis) or pET muscle (y axis) plotted as log 2 fold-change value in each condition. Each point represents one probe-set. Colour scheme as in (a) and (b) with outliers in grey/black. relationship between common genes would result. However, we observed an upward shift in the majority of the 46 ET/pET probesets corresponding to a greater magnitude of expression in pET compared with ET samples (Figure 1c) . The suggestion that saline ET is a mild process was confirmed by simultaneous cluster analysis of arrays and probe-sets, which showed that the global profiles of CN and ET muscle were not intensely different, whereas pET arrays were grouped separately owing to the immune response to plasmid (Supplementary Figure 1) .
GO Biological Process term mapping
Global analysis of the arrays identified two important groups of interest: 46 common genes representing the fundamental muscle damage and repair response after ET and 421 genes induced specifically by plasmid ET. To obtain a biological description of these two groups, we looked for over-represented GO Biological Process terms and pathways. 15 To compensate for GO term redundancy, where one gene often has multiple terms, or alternatively, where genes have no annotation, we expanded this analysis with PubMed searching to associate each probe-set with a single GO Biological Process term (Figure 1b) . Among the 46 common tissue response genes, we found a statistical over-representation of GO terms associated with muscle function and an immune/inflammatory response (Figure 1b ), comprising 13/46 (28.3%) and 16/46 (34.8%) of probe-sets, respectively. The genes associated with these probe-sets represent the fundamental muscle damage and repair response after ET (see below). Statistical analysis of the 421 probe-sets specifically upregulated in pET muscles identified 216 significantly enriched GO terms, with 137 (63.4%) of these associated with immune system processes (data not shown). To refine these data, the list of GO terms was selectively reduced to the nodes of the GO tree with the most descriptive terminology and the least functional redundancy among daughter terms to ensure complete representation of the gene list (Supplementary Table 8 ). Immune-associated genes were thus reduced to 14 key nodes corresponding to 143/421 probesets (34%) (Figure 1b ; Supplementary Table 5) .
Common tissue response genes Among the 46 commonly upregulated probe-sets, we found statistical over-representation of genes associated with muscle function and an immune/inflammatory response. Of the musclerelated genes, we identified 11 genes (Tnnt1, Tnnt2, Tnni1, Mybph, Myl4, Myh3 (myosin heavy chain 3), Actc1, Ankrd1, Sln), which were associated with muscle structure and contraction, and therefore represent repair/replacement of muscle fibres lost through the injection process (Figures 1b and 2a ; Supplementary Table 3) . We also identified paternally expressed 3 (Peg3/Pw1), an imprinted gene and putative satellite cell marker with a role in muscle wasting, 16 and heat-shock protein 7 (Hspb7 or cvHsp). Hspb7 is known to be enriched in the heart, muscle and insulin-sensitive tissues, which may be upregulated in response to damage or the electric field. 17 An additional transcription factor also potentially associated with the electric field was Krü ppel-like factor 4, which has been shown to play a role in heat-related stress. 18 In addition to muscle-related genes, 16/46 commonly upregulated probe-sets were associated with immune, defence and inflammatory responses (Figures 1b and 2b) . These probe-sets had diverse functions corresponding to only one significantly enriched GO term, major histocompatibility complex antigen processing. Major histocompatibility complex antigens and some proteases associated with antigen proteolysis, like cathepsin S, have been shown to be upregulated during muscle regeneration, after tissue damage or in disease states. 19 In addition, several interferon (IFN)-responsive genes, including members of the p200 (Ifi202b, Ifi203) and p47 GTPase families (Iigp1, Igtp), 20 were also modestly upregulated. Monocyte cell markers CD68, Ms4a7 and Zbtb20 were also identified, confirming recruitment of these cells to clear debris and dead cells from the injection site, in agreement with the histological analysis (Supplementary Figure 2) . Importantly, the muscle and immune response probe-sets described here showed a greater upregulation in pET muscle compared with ET muscle (Figures 1c and 2a, b) .
Genes specifically upregulated by plasmid DNA Statistical analysis of the 421 probe-sets specifically upregulated in pET muscles revealed a very high proportion of immune and defence response genes (Supplementary Table 8 ; Figure 1b ). This immune response can be divided into several major components: (i) upregulation of PRR genes capable of recognising intracellular nucleic acids; (ii) upregulation of key signalling and adapter molecules associated with these PRRs; (iii) upregulation of several IFN response factor (IRF) transcription factors that orchestrate the innate immune response; (iv) upregulation of a vast array of IFN response genes; and (v) upregulation of other immune system elements such as co-stimulatory molecules, chemokines, cytokines and complement proteins ( Figure 3 ).
Since the plasmid was non-coding, the immunological response was not due to the presence of a foreign protein. As we did not see any of these 143 immune-associated probe-sets twofold or more upregulated after saline ET (Figure 1 ), we hypothesised that the DNA was initiating an immune response by acting as a ligand for innate immune system PRRs. Commercial testing confirmed plasmids as endotoxin free in undiluted samples, ruling out LPS stimulation (data not shown). DNA, especially unmethylated CpG DNA, is recognised by TLR9, 10 whereas methylated double-strand DNA can also be recognised by many newly described cytoplasmic PRRs, including Zbp-1, 21 HMGB, 22 Dhx36, 23 Ifi16 (Ifi204) 24 or single-strand DNA by Trex1. 25 RNA variants can be recognised by the retinoic acid-induced gene-like helicase family that includes the 2 0 -5 0 -oligoadenylate synthetase (Oas) subfamily. 26, 27 We first searched the array data for genes associated with these families of PRR molecules and their downstream pathways, some of which overlap.
Within the TLR9 pathway, we identified a strong upregulation of the TLR9 transporting protein Unc93b1, 28 but not TLR9 itself or any other TLR (Figure 3a) . The key signalling protein MyD88 was increased 1.79-fold in pET muscles, but remained unchanged in ET muscle. The adaptor protein Irak1 was almost twofold downregulated after saline-only ET (0.53 relative expression) and upregulated to near-normal levels in pET muscle (1.19 relative expression), a twofold increase, whereas we could not detect a significant fold change in the other adaptor molecules Tbk1 or STING (Tmem173), which are implicated in vaccine action. 29 In addition to the TLR9 pathway, we identified respective 4.67-and 1.60-fold upregulation of cytoplasmic DNA detectors Zbp-1 and Trex1 after plasmid ET, but not saline ET, whereas Dhx36 was mildly upregulated in ET, but not pET samples (Figure 3a) . Figure 3 . Electrotransfer with non-coding plasmid DNA is associated with the upregulation of innate immune system genes. Array data were organised into subsets to reflect different arms of the innate immune system responsible for (a) nucleic acid recognition, including the inflammasome; (b) IFN response gene, including members of the p47 and GBP GTPase families and co-stimulatory molecules for antigen presentation; (c) innate immune signalling genes and transcription factors; and (d) cytokines and chemokines. Bars show log 2 fold-change ( ± STD) values for ET (white) and pET (black) samples for selected probe-sets. Dotted lines represent the limit of twofold up-or downregulated.
No upregulation of Hmgb1 or Ifi204 was seen (data not shown). Several molecules associated with the recognition of non-self RNA molecules were also upregulated, including Mda5, Oas1a and Oasl2, but not PKR (Eif2ak2) (Figure 3a) . Within the inflammasome, we identified a very strong 4.28-fold upregulation of Asc (Pycard) (Figure 3a) , whereas expression changes in the other key inflammasome genes AIM2 and Nlrp3 (Nalp3) were not detected (data not shown). However, a modest 1.66-fold upregulation of Hsp90aa1, which may bind inactive Nlrp3, was seen. The specific upregulation of innate immune system PRRs after plasmid ET is likely due to positive feedback induced by initial recognition of plasmid DNA by PRRs, subsequent signalling and type I IFN production, which in turn induces further upregulation of PRRs. 30 However, the specific upregulation after plasmid ET of both TLR9 and many newly described PRRs able to detect cytoplasmic DNA reveals the potential involvement of many new pathways in mediating plasmid clearance from muscle and/or immune responses to gene transfer.
Many genes associated with downstream events of innate immune system activation were also upregulated in the presence of plasmid, but not saline. Plasmid DNA induced upregulation of members of the p47 and p200 GTPase and GBP GTPase families, in addition to those associated with the 46 common tissue response genes (Figures 2b and 3b) . Importantly, several co-stimulatory molecules involved in antigen presentation and associated with the muscle 31 were also induced by plasmid DNA (Figure 3b ) in addition to many less characterised IFN-responsive genes not seen after saline ET (data not shown). Several important signal transducers and IRF transcription factors were also specifically upregulated after plasmid ET (Figure 3c ). In particular, we identified upregulation of Stat1 and IRF7, but not IRF3, which is believed to be an important signal transducer from Zbp-1. 32, 33 Strong upregulation of IRF8 and IRF1 was also observed (Figure 3c ). Finally, many cytokines, chemokines and associated molecules were specifically upregulated after plasmid ET (Figure 3d) , as well as an extensive array of complement genes and more muscle structural genes (data not shown). Collectively, these data suggest that non-coding plasmid DNA potentiates the common tissue response observed after saline ET. However, more importantly, plasmid ET also initiates a strong innate immune response to the presence of DNA that appears mediated by, or at least causes upregulation of, TLR9-dependent and -independent pathways and inflammasome components, as well as costimulatory molecules that may facilitate antigen presentation to CD8 T cells. 31 Kinetics of cellular infiltration In addition to upregulation of immune system genes, we also saw evidence of tissue infiltration through increases in genes associated with cellular transport, cellular adhesion and migration, extracellular matrix organisation as well as some cell death, probably associated with phagocytosis of damaged cells (Figure 1b; Supplementary Table 9 ). Further characterisation of the inflammatory response was performed by histology, fluorescence-activated cell sorting (FACS) and qPCR of marker genes on whole-tissue lysate taken at different time points after ET (Supplementary Figure 2 --5) . These experiments were performed with two additional plasmids, pDCMV and pCpG-free plasmids. pDCMV was the same as the parental pCMV, except that the regulatory elements were removed to avoid any ectopic transcription of the plasmid backbone. A commercial non-coding pCpG-free plasmid was used to minimise activation of the TLR9 pathway, classically considered the dominant route for cellular detection of plasmid and un-methylated CpG DNA.
We saw an increase in total single-cell yield from muscle treated with both standard and CpG-free plasmids compared with salineinjected animals, in agreement with the global gene expression changes and hematoxylin staining (Supplementary Figures 2  and 3a) . FACS analysis of the infiltrating cells revealed two important differences between treatments. Firstly, in addition to showing significantly less infiltrate than plasmid ET, saline treatment was associated with a more rapid resolution of tissue repair as seen by the switch from pro-to anti-inflammatory macrophages already by day 3, as measured by the number of CD45 Figures 3b and 4a) . 34 Secondly, the pro-inflammatory phase of macrophage infiltration was significantly different between pDCMV and pCpG-free treatments at day 7, but not at day 3. We saw statistically more proinflammatory macrophages in pDCMV compared with pCpG-free plasmid at day 7 by absolute number (74 279 Table 10 ). Since the only major difference between the two treatments is the DNA backbone, it is likely that different profiles of PRR interaction were able to trigger the sustained response.
FACS also showed that there were more granulocytes (CD45
Àve /Ly6C þ ve cells, including neutrophils) at earlier stages after saline or DNA ET, coincident with the peak of pro-inflammatory macrophages and inflammatory markers seen by qPCR (Supplementary Figures 3 --5 and see below) , which then decrease. Lymphocyte numbers (CD45
þ ve ) were also seen to peak early and wane as repair proceeds, but formed an unimportant total fraction of CD45 þ ve cell infiltrate (B0.5% at maximum) ( Supplementary Figure 3b and 4a) . Increased CD8a was detected by qPCR after ET compared with untreated muscle, but despite this, the high Ct values indicated insignificant mRNA levels (Supplementary Figure 4b; data not shown). Taken together, these data suggest that T cells are unlikely to contribute significantly to the immune response to plasmid ET or to the gene expression profiles at the times examined. Another important cell type is natural killer (NK) cells, which are mediators of innate immunity in response to a variety of pathological challenges and are normally identified by the expression of CD56 and CD161 (NK1.1), but the absence of F4/80 and Ly6G. 35 We were unable to co-isolate NK cells by FACS with our protocol, but as the four major populations described above comprise 490% of CD45 þ ve cells at days 1 and 3 and 470% of CD45 þ ve cells at day 7 with conservative gate placement to maximise population purity, it is unlikely that NK cells contribute more than a maximum of 10% of the total population after ET (data not shown). The expression of CD161 by qPCR suggested a slower resolution of NK cells than either granulocytes or lymphocyte, but not macrophages, with the expression being higher at intermediate stages of infiltration rather than early stages (Supplementary Figure 4b) . Immunofluorescence confirmed the presence of neutrophils (Ly6g Figure 5) . Once infiltration had cleared, around 14 days, signs of central nucleation and thus muscle regeneration were not extensive, confirming that ET is well tolerated.
Kinetics of the innate immune response
To validate the microarray data and to further correlate the gene expression signature with the kinetics of cellular infiltration, we performed qPCR on a set of marker genes created to represent the different facets of the tissue response to saline and plasmid ET (Supplementary Table 11 ). The list included several IFN and cytokine genes not identified in the arrays that have been previously implicated as effectors of innate immunity (for example, TLR3, TLR9, IRF3, IL-6, IFNs). For most genes present in both the arrays and marker gene list, we saw a strong agreement between fold-change values when comparing the same conditions of dose and time, validating the reproducibility of the gene expression signature (see exceptions below).
The first group of genes we examined were the PRRs associated directly with detection of nucleic acids. We found that Zbp-1 and Asc were not expressed in untreated muscle, whereas several other PRRs were (Figure 4a) . Both pDCMV and, to a lesser extent, pCpG-free plasmids induced rapid and strong induction of TLR9, TLR3, the TLR9 trafficking molecule Unc93b1, as well as other PRRs (Figure 4a ). However, TLR9 and TLR3 expression returned to undetectable (baseline) or near-baseline levels by 7 days, explaining why they were not detected in the arrays. A similar pattern was observed for the inflammasome gene Nlrp3 (Figure 4a ), whereas Aim2 remained more elevated in disagreement with the array data where it was not detected, although probes were present (data not shown).
IRF7 showed an extended duration of expression lasting up to 14 days (Figure 4b ), whereas IRF3 did not show any change (Figure 4b ). No upregulation of either type I or type II IFN mRNA was seen in the arrays (data not shown), despite the significant involvement of IFN-responsive molecules (Figures 3 --5) . 30, 36 However, this result is explained by the rapid up-regulation and return to baseline shortly after 24 h shown by qPCR (Figure 4 ; data not shown), a pattern also observed for the inflammasome cytokine IL-1b. In contrast, IL-6 and IFN-g both showed more sustained upregulation, particularly and significantly with pDCMV than pCpG-free plasmid (Figure 4 ). Of the IFN response genes, Ifi203 showed conventional induction kinetics, with a rapid early induction with a gradual fall in levels by 14 days. However, Iigp1 was significantly induced to greater levels and for longer durations of expression after ET with pDCMV than with pCpG-free plasmid, correlating with the different patterns of pro-inflammatory macrophage infiltration. Similarly, the Cxcl10 chemokine showed a similar, sustained pattern of induction with pDCMV when compared with pCpG-free plasmid. IL-2, which is a potent pro-inflammatory cytokine, showed greater upregulation with pDCMV than pCpG-free plasmid, whereas most other cytokines tested (IL-4, IL-5 and IL-12) showed only modest upregulation with no observable difference between treatments (Figure 5c ). Overall, these data reveal little difference between pDCMV and pCpG-free plasmids in terms of the profile of induced genes, although the majority of genes showed a reduced intensity of upregulation with pCpG-free plasmid.
Dose --response increase in plasmid-specific innate immune response We next assessed the relationship of muscle repair and immunity in a dose --response experiment 7 days after injection of pCMV. Higher doses of pCMV produced proportionately greater upregulation of genes associated with innate immune responses and nucleic acid detection (Asc, Zbp-1, Unc93b1, TLR9 and Oas1a; Figure 5a ). We also observed dose-dependent upregulation of the key transcription factor IRF7, whereas IRF3 showed no change in agreement with array data (Figure 5b) . Induction of the p200 GTPase Ifi203 was only modestly increased with greater plasmid dose, whereas cathepsin S was induced in a dose-dependent manner. In contrast, genes associated with the ET process (MyoD, Hspb7 and Krüppel-like factor 4) remained stably upregulated at B2-fold independently of plasmid dose in agreement with array data, whereas myh3, a marker of muscle damage/repair, showed a dose-dependent induction (Figure 5c) .
Finally, to demonstrate that specificity of the innate immune response was due to the detection of plasmid, and not the inflammation-coupled repair process, we analysed the expression of several genes in a model of skeletal muscle regeneration. ET was performed without hyaluronidase pretreatment or DNA injection to damage the muscle and cause a greater extent of tissue infiltration and repair than saline alone or plasmid ET (Figures 5d and e) . At 4 days after inducing muscle damage, we were unable to detect the upregulation of genes associated with nucleic acid detection (IRF7, TLR9 and Asc), genes that were induced in the presence of plasmid DNA. However, extensive upregulation of tissue damage marker myosin heavy chain 3 was observed in agreement with the extent of tissue infiltration (Figures 5d and e) . TLR3 and IRF3 showed no significant upregulation or difference between any of the three conditions at the time point examined, further suggesting that they are not transcriptionally regulated or do not respond to plasmid DNA or tissue damage. These data demonstrate that the innate immune response is not a passive mechanism associated with inflammation and repair, but is a specific response to the detection of plasmid DNA and that the type of DNA can also greatly influence the inflammatory response.
DISCUSSION
We have used microarray analysis and FACS to characterise the molecular and cellular signature of the tissue repair and immunological response to ET with both saline and non-coding plasmid DNA. ET itself was demonstrated to be a mild process, although we identified several markers of muscle damage and a mild inflammatory response. However, a large and specific upregulation of many PRRs able to detect nucleic acids in addition to other genes associated with innate immunity was observed when administering non-coding DNA. Similar patterns of gene upregulation were observed with both conventional CpGcontaining and CpG-free plasmids, although the magnitude of induction was generally diminished when using the later. This correlated with a more rapid resolution of inflammation, suggesting that the different profile of PRR interaction can have important consequences on the intensity and duration of the immune response. Important pathways and molecules identified are summarised in Figure 6 .
ET was first shown to be a mild process as the number and magnitude of gene expression changes were not extensive and infiltration limited in duration and cell number. This is in agreement with other reports, 37, 38 although these studies did not detect upregulation of heat-shock proteins or immune genes. This is explained by the different doses, plasmids, electrical parameters and arrays used. Although we detected a very modest upregulation of muscle-enriched Hspb7 and some immune and inflammatory genes in ET muscle, we did not detect upregulation of PRRs or inflammasome genes. Thus, although ET is known to cause temporary and mild ionic disturbances in muscle, 39 there was no evidence that the ET procedure is able to act as a damageassociated molecular pattern to prime the inflammasome ( Figure 6 ). The role of the inflammasome in response to ET is an important consideration in DNA vaccine design as ET can enhance DNA vaccine effectivity, 40, 41 whereas the action of the important vaccine adjuvant aluminium (alum) is thought to require the inflammasome. 42 For this reason, it will be important to investigate the use of newer ET protocols on the effectivity of vaccine action as it may be possible that, as well as improving plasmid distribution and expression, some damage may be necessary to prime detection of the vaccine plasmid and encoded antigen.
A total of 46 common tissue response probe-sets were also identified, which showed a greater upregulation in pET muscle compared with ET muscle, suggesting that muscle damage and repair is amplified by the presence of non-coding plasmid DNA, which may be undesirable in a clinical setting, especially if repeated administration is necessary. In addition to this amplified tissue response was the large number of genes specifically upregulated in the presence of plasmid DNA. Many of these genes are identical to those identified in similar models of virus transduction. 43 --45 This is not surprising as viral immunity is composed of immune responses to viral capsid proteins and also to the viral genome once released into the cytoplasm. Thus, although non-viral gene transfer avoids capsid immunity, there are likely to be consequences of innate immune recognition of nucleic acids that may hamper the efficiency or longevity of gene transfer while potentially benefiting DNA vaccine action. Although this has been known for TLR9, our data also highlight the potential impact of other, newer PRR pathways.
A similar pattern of gene induction was observed for both standard and CpG-free plasmids, albeit at different magnitudes, thus emphasising the role of TLR9-independent mechanisms in immune response to non-viral gene delivery. Vaccine action is already known to occur in the absence of TLR9 signalling, requiring the molecule Tbk1, which is thought to bridge PRR signalling to transcriptional activation. 29, 46 However, in our array analysis, we did not detect upregulation of Tbk1 or the related molecule STING, which may partially explain the often limited immunogenicity of muscle in some trials. 41 Furthermore, vaccine action has shown to occur in the absence of Zbp-1, meaning that other pathways, or a combination of pathways, are critical for vaccine action in skeletal muscle. 29 Our data also show that subtle modifications to the DNA, and thus their profile of detection by PRRs, can alter the intensity and duration of inflammation, and consequently the molecular signature of the innate immune response. Future studies are likely to reveal additional pathways for nucleic acid detection, as well as potentially important tissue differences in these pathways. Another important point for future study will be to examine if and how the innate system induced by plasmid ET in skeletal muscle is able to activate the adaptive immune system and how it differs from other key vaccine target tissues such as skin. Many co-stimulatory molecules were identified to be upregulated specifically after plasmid ET, whereas tissue damage was also associated with the upregulation of some major histocompatibility complex molecules that may impact vaccine function and/or limit gene therapy applications. 8, 31 A positive feedback loop exists whereby most or all of the PRRs and DNA detection processes are induced by PRR signalling and the resulting IFN response. 30 Thus, activation of one pathway will essentially upregulate many other pathways, making it difficult to discern the contributions of each pathway to DNA detection. Careful regulation of the immune response, especially in the context of this positive feedback loop, is an important consideration. Mechanisms must thus exist to both diminish transcription of IFNs, which peak early at o24 h, despite the sustained presence of many signalling and IFN-responsive genes. Similarly, the prolonged pro-inflammatory phase of infiltration observed with conventional plasmids compared with CpG-free plasmids is likely due to the different patterns of DNA detection by PRRs, and consequently differential involvement of downstream signalling molecules and transcription factors. That is, the presence of important regulatory genes able to balance the inflammatory response between effectiveness in the absence of excess will be important to identify. Similarly, their mechanism of regulation will require additional studies beyond gene expression analysis. As one example, here we have identified strong induction of IRF7, but not IRF3 (Figure 6 ). Although both have an important role in PRR signalling, IRF3 has been implicated as the key downstream effector of Zbp-1 and many PRRs. 32, 33 The predominant induction of IRF7 over IRF3 may suggest different mechanisms of detection and signalling or different transcriptional programmes, although post-translational, rather than transcriptional, regulation of IRF3 is more likely. Evidence suggests that an important role for IRF3 in mediating the immune response is still likely without marked upregulation and the two different modes of regulation are important considerations for how muscle orchestrates an immune response. In particular, the dose-dependent induction of IRF7 we observed suggests that vaccines might produce better results at higher doses, whereas gene therapy applications may need to reduce the maximum dose to avoid or limit immune activation. In the same way, one limitation of our analysis is that gene expression studies do not identify proteins whose activity is regulated translationally or post-translationally, such as by stability or phosphorylation. Future studies with knockout mice or using genetic tools and/or pharmacological intervention will be important to dissect the relative contributions of the different PRRs and their key signalling molecules to the magnitude and the propagation of the immune response and how they contribute to vaccine function.
In conclusion, we demonstrate that plasmid DNA induces upregulation of several arms of the innate immune system. The upregulation of both TLR9 and several alternative, newly described PRRs for cytoplasmic DNA detection, like Zbp-1 and the inflammasome, were also detected. PRRs showed dose --response induction kinetics and a near-identical molecular signature was induced by both conventional and CpG-free plasmids, with the reduced magnitude of expression induced by CpG-free plasmids correlating with the resolution of infiltration. Finally, we have generated and tested a list of marker genes that will be useful for validating the safety and immunotoxicological profiles of other ET protocols and different DNA technologies such as minicircles and has the potential to be adapted to high-throughput screening and even screening different tissues.
MATERIALS AND METHODS Animals
CD1 male mice were used for all studies and fed ad libitum with a standard diet (Teklad 2018S; Harlan Teklad, Blackthorn, UK) and maintained under a light-dark cycle of 12 h (lights on at 0800 hours). Animal care and experimental procedures were approved by the Ethics Committee in Animal and Human Experimentation of the Autonomous University of Barcelona.
Plasmids
We used transgene-free pCMV, derived from pGG2 (Genethon, Evry, France), for arrays and qPCR. The same plasmid cut with PvuII and re-ligated to remove the regulatory sequences (pDCMV) and the CpG-free plasmid pCpG-mcs G2 (InvivoGen, Toulouse France) were used for time-course analysis as indicated. All plasmids were purified using the Endofree plasmid kit (Qiagen, Crawley, UK), which guarantees endotoxin levels o0.1 EU/mg plasmid and dissolved in endotoxin-free 0.9% NaCl for injection. Endotoxin levels were measured by Lonza (Basel, Switzerland) and found to have no detectable endotoxin in undiluted samples (data not shown).
Electrotransfer
Mice were treated when 2 months old. Firstly, mice were anesthetised with ketamine/xylacine and 2 h before ET, each target muscle was pre-treated with hyaluronidase (bovine testes type VII; 10 U per muscle; Sigma, St Louis, MO, USA) before injection with a 30 ml volume of either saline or plasmid as indicated (75 mg pCMV for array studies). Electrical parameters were: 10 pulses of 20 ms each at 175 V/cm and 2 Hz BTX ECM 830 electroporator (BTX, Gene-tronics, San Diego, CA, USA).
Microarray samples and analysis
To prepare total RNA for microarray analysis, we used one whole tibialis anterior taken 7 days after treatment. We used the recommended Affymetrix protocol for RNA extraction (Expression Analysis Technical Manual; http://www.affymetrix.com). Briefly, each tibialis anterior was homogenised Trizol (Invitrogen, Carlsbad, CA, USA) before precipitation and column purification (Qiagen, Hilden, Germany). On-column DNase I digestion was carried out (Qiagen). All following steps were performed by Progenika (Bilbao, Spain; http://www.progenika.com/). We used 4.5 mg of RNA to synthesise cDNA with the One Cycle cDNA synthesis kit (Affymetrix, Santa Clara, CA, USA), a part of which was used to make biotinylated cRNA using the IVT Labelling kit (Affymetrix). Labelled cRNA samples were hybridised to GeneChip Mouse Genome 430A 2.0 arrays (Affymetrix). The software used was GeneChip Operating Software (GCOS 1.4; Affymetrix). Bioinformatics and normalisation using Robust Multichip Averaging were performed using GeneSpring GX v.7.3.1 (Agilent; http: //www.agilent.com), dChip (http: //www.dchip.org), as well as Affy and affyPLM (BioConductor; http: //www.bioconductor.org). The final gene list contained only those probe-sets with a Po0.05 (Benjamini and Hochberg). For the interpretation, cross-checking and visualisation of the data, we used AmiGO Term Enrichment and GO Slimmer (release 2008-10-07), GO Term Finder. 15 Cluster (version 3.0) and Tree View (version 1.60) 47 to perform cluster analysis using Euclidean distance algorithms of log-transformed, normalised raw data. Array data have been submitted to MIAMExpress (E-MEXP-2191).
FACS
Briefly, isolated muscles were weighed, minced and digested in 0.05% pronase solution (Calbiochem, Damstadt, Germany) for 60 min at 37 1C with agitation. Tissue residue was removed by filtration through 100 mm Steriflip filters (Millipore, Carrigtwohill, Ireland). Cells were pelleted by centrifuging at 900 g for 5 min at 25 1C, washed in phosphate-buffered saline and resuspended in 2 ml of FACS Lysis Buffer (BD Pharmingen, San Diego, CA, USA) for 10 min in the absence of light to lyse erythrocytes. The reaction was stopped by dilution in phosphate-buffered saline and cells were pelleted as before, resuspended in 100 ml of phosphate-buffered saline/1% fetal bovine serum and counted in a hemocytometer. Excess cells were removed and pooled for distribution between negative and compensation CNs (min. 50 000 cells per CN), while all remaining samples were processed individually. Firstly, cells were blocked with 0.5 mg rat antimouse CD16/CD32 (Fc block; BD Pharmingen) for 10 min and then the following anti-mouse antibodies added: FITC CD45 (clone 30-F11; 0.25 mg; BD Pharmingen), APC-Cy7 F4/80 (clone BM8; 0.2 mg; BioLegend, San Diego, CA, USA), PE Ly6c (clone AL-21; 0.1 mg; BD Pharmingen), APC CD3 (clone SK7; 0.25 mg; eBioscience, San Diego, CA, USA). Cells were washed in phosphate-buffered saline/1% fetal bovine serum and 4 0 ,6-diamidino-2-phenylindole added 10 min before processing samples on a BD LSR II Flow Cytometer (Becton Dickinson, San Jose, CA, USA). Data analysis were performed using the BD FACSDiva (version 6.1.2, Becton Dickinson) and GateLogic (version 307.1A) software (eBioscience).
Histology
Muscles were fixed in 4% formol or isopentane-cooled liquid nitrogen, and 6 mm sections cut using a Leica RM-2135 microtome (Leica, Wetzlar, Germany). Images were captured using a Nikon Eclipse 90i microscope and a Nikon DS-Fi1 camera (Nikon Corporation, Tokyo, Japan). Primary antibodies were rat anti-mouse Ly6g (BD Pharmingen) and rat anti-mouse F4/80 (AbD serotec), whereas fluorescent secondary antibodies were from Dako (Hamburg, Germany).
Quantitative real-time RT-PCR For qPCR, 2 mg of total RNA was used as a template to synthesise cDNA (Omniscript kit; Qiagen). qRT-PCR was performed in a SmartCycler II (Cepheid, Sunnyvale, CA, USA) using QuantiTect SYBR Green PCR kit (Qiagen). Primer sequences are shown in Supplementary Table 10 . Data were normalised with 36B4, cross-validated with b-actin and analysed as described. 48 ABBREVIATIONS ET, electrotransfer; OAS, 2 0 -5 0 -oligoadenylate synthetase; PRR, pattern recognition receptor; TLR, Toll-like receptor.
